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nd Protective Effects
t was of deep interest for me to read the article by Hamer et al. (1)
n cardiovascular risk and secondhand smoke (SHS) exposure.
fter having analyzed data on salivary cotinine measurements in
ore than 13,400 middle-aged English and Scottish adults, the
nvestigators concluded that participants exposed to high SHS
21% of the total sample) had: 1) elevated levels of low-grade
nflammation; and 2) elevated risk of cardiovascular death (over a
ollow-up of 8 years) that was partly accounted for by the former
hange.
Both conclusions seem to be far from convincing and
bjective. When the mean cotinine levels in current smokers is
onsidered 100, those in high SHS was 1 and those in the
edium SHS category 0.06. The referent group (one-eighth of
he sample) represented virtually the unexposed category. A
iologic parameter that shows a more than 1,500-fold variation
cross active and passive smokers cannot be used as a continu-
us parameter over the whole range. Indeed, Cox regression
nalyses indicated that the association between cotinine cate-
ories and both the overall and cardiovascular mortality is not
inear: it was lowest in the medium SHS category (65% of
onsmokers exposed to SHS), which hence deserves the great-
st attention.
Compared with the referent group, the medium SHS category
isplayed no differences in any of the 4 studied parameters:
igh-density lipoprotein cholesterol, fibrinogen, C-reactive pro-
ein (CRP), and systolic blood pressure. Because systolic blood
ressure was unchanged even in smokers, CRP was the only
arameter that was raised in the high SHS category significantly,
lbeit marginally. The increment in CRP, 1.2-fold, is one-sixth of
SD, given that 1 SD represents 3-fold values (2). Because such
n increment, adjusted for conventional risk factors, confers a
azard ratio (HR) of 1.37 (2), the elicited difference corresponds to
erely 1.05, not likely to have a significant influence on the
tudied risks.
In Cox regression models 2, compared with the referent
nexposed group, the medium SHS category revealed a borderline
ignificantly lower mortality (by 15%) and again 15% lower
ardiovascular deaths, although the difference is insignificant
wing to limited statistical power. High SHS displays HRs for
verall and cardiovascular mortality similar to the unexposed group
despite a higher prevalence of diabetes).
To sum up, what one can conclude from this paper on the issue
f SHS and cardiovascular risk is that the influence of salivary
otinine (by inference, plasma nicotine) is nonlinear but exerts a
hreshold effect. High exposure to SHS confers no excess cardio-
ascular or all-cause mortality compared with unexposed individ-
als, whereas moderate SHS exposure (representing the majority
f passive smokers) tends to reduce the risk of death, by approx-
mately 15%. This inference is not surprising in view of the lact that even active smoking has been reported to have beneficial
ffects on the risk of type 2 diabetes (3) and marginal effects on the
isk of coronary heart disease in the general population (4); in
ddition, there have been reduced fasting glucose levels among
mokers (5).
The data of Hamer at al. (1) thus call for globally reassessing the
ogmatic acceptance of an adverse relation between active and
assive smoking and cardiovascular risk, requiring taking into
ccount genetics, sex, ethnicities, degree of exposure, and glucose
ntolerance.
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eply
e thank Dr. Onat for his comments on our recent paper (1).
egarding the first issue, it would indeed be inappropriate to
odel cotinine as a continuous parameter because it has a large
ariation and highly skewed distribution. That is why we
ransformed cotinine into a categoric variable, which is consid-
red a standard epidemiologic approach to deal with this issue.
hen creating a categoric variable, it is inevitable that arbitrary
ut points will be used, and this might be one reason for the lack
f linearity observed. Dr. Onat alludes to the medium second-
and smoke (SHS) category having a borderline significantly
ower risk; however, in fact, the 95% confidence intervals for
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November 30, 2010:1962–3ardiovascular disease (CVD) death in the fully adjusted model
0.62 to 1.19) provide no robust evidence for an association.
urthermore, the results in never-smokers do suggest a clear
inear association between SHS and CVD death (hazard ratios
or medium and high SHS categories are 1.28 and 2.22,
espectively). The inclusion of ex-smokers in the main analyses
ight have considerably masked the true effects of SHS because
x-smokers already have an excess risk of mortality (2), and thus
he presence of ex-smokers in the low SHS-exposed group may
ilute the effects.
In relation to the issue regarding C-reactive protein (CRP), we
gree that these data should be viewed cautiously because it is
nclear if CRP does play a causal role in CVD etiology or is merely
biomarker (3). In the present studied cohort, CRP is indepen-
ently associated with CVD events, although it does not add
rognostic significance to established models such as the Framing-
am risk score (4).
Last, we are certainly not in agreement with Dr. Onat’s opinion
hat our data call for reassessing the acceptance of an adverse
elation between active and passive smoking and CVD risk. Our
ata clearly show a strong association between active smoking and
VD, which is consistent with a plethora of previous epidemio-
ogic evidence over the past few decades. We believe our data also
upport an association between SHS and CVD, especially in
ever-smokers. Future large-scale studies, such as the recent data
rom the European Prospective Investigation into Cancer and
utrition (5), are required to further explore this potentiallymportant public health issue.Mark Hamer, PhD
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